Your browser doesn't support javascript.
loading
Time-programmable drug dosing allows the manipulation, suppression and reversal of antibiotic drug resistance in vitro.
Yoshida, Mari; Reyes, Sabrina Galiñanes; Tsuda, Soichiro; Horinouchi, Takaaki; Furusawa, Chikara; Cronin, Leroy.
Afiliação
  • Yoshida M; WestCHEM, School of Chemistry, The University of Glasgow, Glasgow G12 8QQ, UK.
  • Reyes SG; WestCHEM, School of Chemistry, The University of Glasgow, Glasgow G12 8QQ, UK.
  • Tsuda S; WestCHEM, School of Chemistry, The University of Glasgow, Glasgow G12 8QQ, UK.
  • Horinouchi T; Quantitative Biology Center, RIKEN, 6-2-3 Furuedai, Suita, Osaka 565-0874, Japan.
  • Furusawa C; Quantitative Biology Center, RIKEN, 6-2-3 Furuedai, Suita, Osaka 565-0874, Japan.
  • Cronin L; Department of Physics, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Nat Commun ; 8: 15589, 2017 06 08.
Article em En | MEDLINE | ID: mdl-28593940
ABSTRACT
Multi-drug strategies have been attempted to prolong the efficacy of existing antibiotics, but with limited success. Here we show that the evolution of multi-drug-resistant Escherichia coli can be manipulated in vitro by administering pairs of antibiotics and switching between them in ON/OFF manner. Using a multiplexed cell culture system, we find that switching between certain combinations of antibiotics completely suppresses the development of resistance to one of the antibiotics. Using this data, we develop a simple deterministic model, which allows us to predict the fate of multi-drug evolution in this system. Furthermore, we are able to reverse established drug resistance based on the model prediction by modulating antibiotic selection stresses. Our results support the idea that the development of antibiotic resistance may be potentially controlled via continuous switching of drugs.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana Múltipla / Quimioterapia Combinada / Escherichia coli / Antibacterianos Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana Múltipla / Quimioterapia Combinada / Escherichia coli / Antibacterianos Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article